Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2009-07-29

European Medicines Agency update on safety of insulin glargine - Update

View source ↗

Summary

EMA update addressing safety considerations for insulin glargine, summarizing ongoing risk assessments and communications to ensure proper use and monitoring.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)